Annick V. Hartstra

Annick V. Hartstra

Auto-generated profile, based on publicly available information

Annick V. Hartstra

Department of Vascular Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2020 in npj Biofilms and Microbiomes
Verified
Journal Article
Open access
PDF file
PGPim W. Gilijamse
Pim W. Gilijamse
AHAnnick V. Hartstra
Annick V. Hartstra
ELEvgeni Levin
Evgeni Levin
KWKoen Wortelboer
Koen Wortelboer
MSMireille J. Serlie
Mireille J. Serlie
APAndrei Prodan
Andrei Prodan
Dysbiosis of the intestinal microbiota has been implicated in insulin resistance, although evidence regarding causality in humans is scarce. We performed a phase I/II dose-finding and safety study on the effect of oral intake of the anaerobic butyrogenic strain Anaerobutyricum soehngenii on glucose metabolism in 24 subjects with metabolic syndrome. We found that treatment with A. soehngenii was safe and observed a significant correlation between the measured fecal abundance of administered A. soehngenii and improvement in peripheral insulin sensitivity after 4 weeks of treatment. This was accompanied by an altered microbiota composition and a change in bile acid metabolism. Finally, we show that metabolic response upon administration of A. soehngenii (defined as improved insulin sensitivity 4 weeks after A. soehngenii intake) is dependent on microbiota composition at baseline. These data in humans are promising, but additional studies are needed to reproduce our findings and to investigate long-term effects, as well as other modes of delivery.